Pulmonális artériás hipertónia: vizsgálatok itt: Japán
8 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleAn Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Narita, Yokohama
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07234032 · EU 2025-521769-29-00 - 2. fázisTaking peopleClinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Kitakyushu
- Életkor
- 18 év to 75 év
- People
- 135 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441200 · EU 2025-525114-38-00 - 2. fázisTaking peopleA Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Kitakyushu
- Életkor
- 18 év to 80 év
- People
- 177 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441278 - 3. fázisTaking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Bunkyo-Ku, Chiba, Hirosaki, Kiyose, Kyotoshi, Matsumoto, Nagakute, Nagano, Narashino-shi, Narita-shi, Sakai, Sapporo, Seto, Shibuya City, Suita, Tsukuba, Yokohama
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - 3. fázisTaking peopleOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Bunkyō City, Fukuoka, Mitaka, Nagoya, Okayama, Shinjuku-ku, Suita
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Chiba, Kobe, Minato-ku, Mitaka-shi, Narashino, Okayama, Sapporo, Yahatanishi-ku, Kita Kyushu-shi
- Életkor
- 18 év to 75 év
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00 - 2. fázisTaking peopleA Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
- Where
- Izumi, Setagaya City, Suita
- Életkor
- 1 év to 17 év
- People
- 6
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07646860 - 4. fázisTaking peopleA Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
- Where
- Fukuoka, Kobe, Kyoto, Nagoya, Okayama, Sendai, Tokyo
- Életkor
- 18 év and over
- People
- 36
- Run by
- Kazuya Hosokawa
See details and how to joinNCT07356778